ASBP
Price
$0.36
Change
-$0.02 (-5.26%)
Updated
Oct 7 closing price
Capitalization
N/A
SLXN
Price
$4.02
Change
+$0.16 (+4.15%)
Updated
Oct 8, 11:56 AM (EDT)
Capitalization
12.07M
Interact to see
Advertisement

ASBP vs SLXN

Header iconASBP vs SLXN Comparison
Open Charts ASBP vs SLXNBanner chart's image
Aspire Biopharma Holdings
Price$0.36
Change-$0.02 (-5.26%)
Volume$6.81M
CapitalizationN/A
Silexion Therapeutics
Price$4.02
Change+$0.16 (+4.15%)
Volume$559
Capitalization12.07M
ASBP vs SLXN Comparison Chart in %
ASBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASBP vs. SLXN commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASBP is a Hold and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (ASBP: $0.36 vs. SLXN: $3.86)
Brand notoriety: ASBP and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASBP: 22% vs. SLXN: 12%
Market capitalization -- ASBP: $0 vs. SLXN: $12.07M
ASBP [@Biotechnology] is valued at $0. SLXN’s [@Biotechnology] market capitalization is $12.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASBP’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • ASBP’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, ASBP is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASBP’s TA Score shows that 3 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • ASBP’s TA Score: 3 bullish, 7 bearish.
  • SLXN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than ASBP.

Price Growth

ASBP (@Biotechnology) experienced а +74.37% price change this week, while SLXN (@Biotechnology) price change was +13.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was +15.97%, and the average quarterly price growth was +89.17%.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLXN YTD gains are higher at: -87.197 vs. ASBP (-96.877).
ASBPSLXNASBP / SLXN
CapitalizationN/A12.1M-
EBITDAN/A-17.81M-
Gain YTD-96.877-87.197111%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A3.47M-
Total DebtN/A3.7M-
TECHNICAL ANALYSIS
Technical Analysis
ASBPSLXN
RSI
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
15%
Bearish Trend 1 day ago
12%
Momentum
ODDS (%)
Bearish Trend 1 day ago
25%
Bullish Trend 1 day ago
30%
MACD
ODDS (%)
Bearish Trend 1 day ago
24%
Bullish Trend 1 day ago
37%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
38%
Bullish Trend 1 day ago
28%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
37%
Bearish Trend 1 day ago
56%
Advances
ODDS (%)
Bullish Trend 7 days ago
45%
Bullish Trend 8 days ago
53%
Declines
ODDS (%)
Bearish Trend 9 days ago
65%
Bearish Trend 1 day ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
58%
Bullish Trend 1 day ago
50%
Aroon
ODDS (%)
Bearish Trend 1 day ago
46%
Bearish Trend 1 day ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
ASBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KGS34.520.97
+2.89%
Kodiak Gas Services
BTBD1.880.03
+1.62%
BT Brands
TOST37.170.22
+0.60%
Toast
ARVN9.30-0.32
-3.33%
Arvinas
GSIT4.62-0.20
-4.15%
GSI Technology

ASBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASBP has been loosely correlated with SPRO. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ASBP jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASBP
1D Price
Change %
ASBP100%
-6.65%
SPRO - ASBP
58%
Loosely correlated
+3.35%
ALZN - ASBP
43%
Loosely correlated
-2.73%
OCUL - ASBP
25%
Poorly correlated
+5.01%
ORIC - ASBP
25%
Poorly correlated
-2.01%
ATXS - ASBP
24%
Poorly correlated
-2.86%
More